SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-19-000900
Filing Date
2019-04-15
Accepted
2019-04-15 09:56:18
Documents
12
Period of Report
2019-04-15

Document Format Files

Seq Description Document Type Size
1 FORM 6-K aphria6k.htm 6-K 11873
2 FINANCIAL STATEMENTS ex991.htm EX-99.1 871092
3 MANAGEMENT'S DISCUSSION AND ANALYSIS ex992.htm EX-99.2 495457
4 CEO AND CFO CERTIFICATES ex993.htm EX-99.3 18039
5 GRAPHIC mda_pg4.jpg GRAPHIC 18895
6 GRAPHIC mda_pg5solei.jpg GRAPHIC 14488
7 GRAPHIC mda_pg5riff.jpg GRAPHIC 4543
8 GRAPHIC mda_pg5broken.jpg GRAPHIC 9628
9 GRAPHIC mda_pg5gs.jpg GRAPHIC 5846
10 GRAPHIC mda_pg9.jpg GRAPHIC 89946
11 GRAPHIC logo_large.jpg GRAPHIC 11882
12 GRAPHIC mda_footerlogo.jpg GRAPHIC 2595
  Complete submission text file 0001279569-19-000900.txt   1615977
Mailing Address 245 TALBOT STREET W., SUITE 103 LEAMINGTON A6 N8H 1N8
Business Address 245 TALBOT STREET W., SUITE 103 LEAMINGTON A6 N8H 1N8 (844) 427-4742
Aphria Inc. (Filer) CIK: 0001733418 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 0531
Type: 6-K | Act: 34 | File No.: 001-38708 | Film No.: 19747738
SIC: 2833 Medicinal Chemicals & Botanical Products